DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID DISEASE

• 1. 类风湿病的延迟释放糖皮质激素治疗 [P] . 中国专利： CN101466385B . 2014.01.08
• 2. 类风湿病的延迟释放糖皮质激素治疗 [P] . 中国专利： CN101466385A . 2009-06-24
• 3. DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID DISEASE [P] . RS52672B2 . 2018-03-30

  机译： 延迟释放糖皮质激素治疗类风湿病

• 4. DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID DISEASE [P] . PL2049123T5 . 2017-09-29

  机译： 延迟释放糖皮质激素治疗类风湿病

• 5. Delayed-release glucocorticoid treatment of rheumatoid disease [P] . 美国专利： US9504699B2 . 2016-11-29

  机译： 延迟释放糖皮质激素治疗类风湿病

• 1. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNF alpha inhibitors and rituximab [J] . Listing Joachim, Kekow Joern, Manger Bernhard, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2015,第2期
• 2. Oral Low-Dose Glucocorticoids Should Be Included in Any Recommendation for the Use of Non-Biologic and Biologic Disease-Modifying Antirheumatic Drugs in the Treatment of Rheumatoid Arthritis [J] . Roberto Caporali, Monica Todoerti, Carlo Alberto Scire, Neuroimmunomodulation . 2015,第1a2期
• 3. Cost-effectiveness of treatment strategies using combination disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis. [J] . Allan Wailoo, Mónica Hernández Alava, Ian C Scott, Rheumatology . 2014,第10期
• 4. Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy [C] . Johannes W. J. Bijlsma, Marlies C. van der Goes, Jos N. Hoes, International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases . 2010
• 5. Complex Immune Biomarkers of Treatment Response and Disease Outcomes in Rheumatoid Arthritis. [D] . Davis, John M. 2014
• 6. Extended report: Mortality in rheumatoid arthritis: the impact of disease activity treatment with glucocorticoids TNFα inhibitors and rituximab [O] . Joachim Listing, Jörn Kekow, Bernhard Manger, -1
• 7. 098 Use of Disease-Modifying Therapies and Glucocorticoids in the Early Treatment of Rheumatoid Arthritis: Observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis [O] . 2016

• 1. Escin enhances anti-rheumatoid arthritis effects of low dose glucocorticoids through up-regulation of glucocorticoid receptor [J] . ZHANG Lei-ming ,HUANG Ya-nan ,DU Yuan . 中国药理学与毒理学杂志 . 2019,第9期
• 2. THERAPEUTIC EFFECTS OF THE INSTANT RHEUMATOID MEDICINAL GRANULES FOR TREATMENT OF ACUTE RHEUMATOID ARTHRITIS - A Report of 34 cases [J] . 寇秋爱 ,房定亚 . 中医杂志：英文版 . 1997,第3期
• 3. Discussion about different treatments for the same disease and the same treatment for different diseases of Shanghan Lun [J] . Chao-Ning Zhang1 . TMR理论与假说 . 2019,第001期
• 4. A Local Clinical Audit on Osteoporosis Prevention and Management in Sudanese Patients Treated with Long Term Oral Glucocorticoids for Rheumatic Diseases in a Military Tertiary Hospital in West Khartoum [J] . Sara Elhadari ,Hani Hussein ,Alnor Alagib . 内科学期刊（英文） . 2018,第4期
• 5. MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases [J] . Sara De Iudicibus ,Marianna Lucafò ,Stefano Martelossi . 世界胃肠病学杂志：英文版 . 2013,第44期
• 6. EPR核电厂放射性气体释放前运动及延迟滞留状态论证 [C] . ZHANG Xue-ling ,张学岭 ,CHEN Yi-de . 北京核学会第十届（2014）核应用技术学术交流会 . 2014
• 7. 延迟释放微胶囊防气窜水泥浆体系的研究 [A] . 李靖 . 2009